Yahoo Web Search

  1. Ad
    related to Eli Lilly
  1. 5 Cancer-Fighting Stocks to Add to Your Portfolio

    Zacks via Yahoo FinanceSep 03 11:02 AM

    Cancer has become a major health scare in the 21st century, with nearly every individual knowing someone or the other who has been affected. Cancer in layman’s term is a disease that is caused ...

  2. An Oklahoma judge ruled on Monday that large cap pharmaceutical company Johnson & Johnson JNJ would have to pay $572 million to the state. J&J is accused of helping fuel the opioid epidemic ...

  3. Eli Lilly and Co's LOXO-292, a experimental cancer drug the company acquired in January as part of its $8 billion takeover of Loxo Oncology, shrank tumors in nearly 70% of advanced ...

  4. Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class?

    Motley Fool via Yahoo FinanceSep 05 15:12 PM

    In March, the Food and Drug Administration issued a complete response letter -- the agency's euphemism for a rejection letter -- to Sanofi (NASDAQ: SNY) and Lexicon Pharmaceuticals (NASDAQ: ...

  5. Vertex Pharmaceuticals VRTX announced that it has decided to acquire Semma Therapeutics, a privately-held biotech, for $950 million in cash. This acquisition will add pre-clinical cell-based ...

  6. It has been about a month since the last earnings report for Aduro Biotech (ADRO). Will the recent negative trend continue leading up to its next earnings release, or is Aduro Biotech due for ...

  7. J&J's Stelara Gets Approval in EU for Ulcerative Colitis

    Zacks via Yahoo FinanceSep 05 14:18 PM

    Johnson & Johnson JNJ announced that the European Commission (EC) has approved the label expansion of Stelara (ustekinumab) for the treatment of adults with moderately-to-severely active ulcerative ...

  8. This weekend's Barron's cover story offers a look at biotechnology companies developing cutting-edge drugs. Other featured articles discuss the outlook for stocks and bonds in the fall and how to play ...

  9. Failure of Alzheimer’s Disease Study Creates a New Penny Stock

    Bloomberg via Yahoo FinanceSep 09 18:42 PM

    Biogen, Eli Lilly & Co., Roche Holding AG as well as small-cap Cassava Sciences Inc. are developing new medicines that target a pathway called tau.

  10. Tuesday, September 10, 2019 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ...

  1. Ads
    related to Eli Lilly